Trademark Search in Canada

ORITESSE

View On IC.GC.CA

REGISTERED

on 17 Jun 2019

Last Applicant/ Owned by

ABBVIE INC.

1 N. Waukegan RoadNorth Chicago, IL 60064

Serial Number

1812684 filed on 6^th Dec 2016

Registration Number

TMA1027024 registered on 17^th Jun 2019

Registration expiry Date

17^th Jun 2029

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

M5J2T3

ORITESSE

Trademark usage description

pharmaceutical preparations and substances for the treatment of endocrine diseases and disorders, namely, hormone disorders, growth disorders, diabete Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of endocrine diseases and disorders, namely, hormone disorders, growth disorders, diabetes, hypoglycemia, thyroid cancer, glucagonoma, cardiovascular, cardiopulmonary, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal diseases and disorders, namely, hormonal imbalance, hyperthyroidism, hypothyroidism, exocrine pancreatic insufficiency (EPI), uterine fibroids and endometriosis

Classification kind code

Mark Details

Serial Number

1812684

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 11^th May 2018	Allowed
Submitted for opposition 51 on 11^th May 2018	Allowance Notice Sent
Submitted for opposition 42 on 24^th Jan 2018	Advertised
Submitted for opposition 26 on 4^th Jan 2018	Approved
Submitted for opposition 27 on 17^th Nov 2017	Approval Notice Sent
Submitted for opposition 22 on 28^th Aug 2017	Search Recorded
Submitted for opposition 20 on 28^th Aug 2017	Examiner's First Report
Submitted for opposition 31 on 8^th Dec 2016	Formalized
Submitted for opposition 30 on 6^th Dec 2016	Filed
Submitted for opposition 1 on 6^th Dec 2016	Created